Navigation Links
University of Leicester cancer researchers investigate 'smoking gun' trail

The University of Leicester has been selected as the hub of a worldwide network of researchers to investigate one of the causes of cancer.

The study into the smoking gun trail of devastation caused to the body by substances known as free radicals will also impact on our understanding of heart disease, neurodegenerative disease and arthritis.

Dr Marcus Cooke, Senior lecturer in the Radiation and Oxidative Stress Section at the University of Leicester, said: Most of us have heard of free radicals, and the benefits of antioxidants which mop them up - even if it is just from cosmetics commercials.

However, premature aging is just the tip of the iceberg for their detrimental effects. Free radicals have been implicated in many diseases. They are arguably the most prevalent cancer causing chemicals known.

Free radicals are highly reactive, and can cause widespread damage to cells, and in particular DNA - the cell's blueprint. Whilst it is very difficult to measure free radicals themselves, we can measure this damage as a 'smoking gun' signature of free radical activity.

Being able to accurately and sensitively measure this damage will allow us to:

  • get a better understanding of the role of this damage in disease

  • develop assays to determine disease risk, by measuring cell damage
  • design strategies to prevent, or encourage repair, of this damage, and hence prevent disease

This research is particularly important because it provides validated, non-invasive methods for assessing oxidative stress in humans. Being non-invasive this is ideal for looking in young and old patients.

It will allow us to develop reference ranges to identify what levels of damage in urine are normal, or abnormal, for clinical application and to develop disease risk/prognostic tests.

Dr. Cooke has been made PI of a project (Euros 45k) to undertake the Europe-wide validation of a urinary biomarker of oxidative stress.

This is one of two studies where Leicester is playing a lead role. Dr. Mark D. Evans is the Principal Investigator in a Euros 60k study to better understand the sources of biomarkers of oxidative stress in urine.

Both projects are spin-offs from a larger Euros 11 million EU Network of Excellence grant (Environment, Cancer, Nutrition and Individual Susceptibility, ECNIS, of which Professor Peter Farmer, of the Department of Cancer Studies and Molecular Medicine, is the project lead at Leicester. (see link at end of release)

Dr Evans said: These are projects addressing fundamental questions that have been, for the most part, overlooked. Being awarded these two complimentary projects, back-to-back gives us the unique opportunity to address questions that we, and others in the scientific community, have wanted to examine for many years. Likewise, this project incorporates worldwide collaborations between Leicester, Collegium Medicum in Bydgoszcz, Poland; DKFZ (the German Cancer Institute), Heidelberg, Germany; Institute of Cancer Research Sutton, U.K; Medical Institute of Bioregulation, Fukuoka, Japan; and Department of Toxicogenetics, University of Leiden, The Netherlands.

Dr Cooke said: This is a further reflection of the international status of our group within the free radical and biomonitoring community. Through these projects, we are working closely with many of the top research institutes worldwide.

Dr Cooke said Leicester would act as the hub of a worldwide network of more than 17 laboratories comparing methods of measuring damage to DNA, in urine: Once we have agreement between methods, we can apply these methods to the study of DNA damage in disease.


Contact: Dr. Marcus S. Cooke
University of Leicester

Related medicine news :

1. Researchers at Cornell University as been reported using research fund by false claims
2. A new study by John Hopkins University proposes formula for good health
3. James Cook University urges more medical seats
4. Pill splitting program of University of Michigan can save money
5. Distinguished Scientist Award Conferred on University of Rochester Scientists for Work on Preventing Cavities
6. Yale University guidelines for Physicians and Pharmaceutical industry
7. $ 1.7 Million NYSTAR Award for Binghamton University to Flex Electronics Research Muscle.
8. Florida State University declares a breathtaking study which might solve the Hepatitis C Virus maze and find a cure!
9. Hwang Woo Suk Suspended By Seoul National University
10. Vladeck to head the University of Medicine and Dentistry of New Jersey
11. Rice University wins Prestigious Grants from HHMI
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... The OSHA Training ... Institute Education Center headquartered in Northern California, has issued an important reminder to ... their worksites. Employers with workers exposed to high temperatures should establish a ...
(Date:6/27/2016)... ... , ... "FCPX editors can now reveal their media with growing colorful split ... Austin - CEO of Pixel Film Studios. , ProSlice Color brings the split ... now reveal the media of their split screens with growing colorful panels. , ProSlice ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... health professionals, announced today its affiliation with Tennessee Counseling Association. This ... the network of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. ...
(Date:6/27/2016)... California (PRWEB) , ... June ... ... pioneer in the patient payment industry today announced its strategic partnership with ... health system workflows. , The two companies’ proven, proprietary technology combine to ...
(Date:6/27/2016)... Brooklyn, NY (PRWEB) , ... June 27, 2016 ... ... is using cutting edge technology to revolutionize the emergency ambulance transport experience for ... Many are aware of how Uber has disrupted the taxi industry through the ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Australia,s successful biotechnology scientists, Dr Graham ... Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm is seeking ... ASX. Noxopharm is a clinic-ready company with its first ... study later this year. NOX66 ... cancer patients - the ability of cancers to become resistant to ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology: